Assignee
AXSOME MALTA LTD
MT·35 granted patents·16 pending applications·50 citations·filing 2020–2025
Top patents by PatentIndex Score
51 records- 0198US11771666B1Methods of administering solriamfetol to lactating womenAXSOME MALTA LTD·Filed 2022·Granted Oct 3, 2023·3 cites·21 claims
- 0298US11771667B1Methods of administering solriamfetol to lactating womenAXSOME MALTA LTD·Filed 2023·Granted Oct 3, 2023·4 cites·26 claims
- 0397US11986455B2Methods of providing solriamfetol therapy to subjects with impaired renal functionAXSOME MALTA LTD·Filed 2023·Granted May 21, 2024·2 cites·24 claims
- 0497US11969404B2Methods of providing solriamfetol therapy to subjects with impaired renal functionAXSOME MALTA LTD·Filed 2023·Granted Apr 30, 2024·2 cites·18 claims
- 0597US11872204B1Methods of administering solriamfetol to lactating womenAXSOME MALTA LTD·Filed 2023·Granted Jan 16, 2024·2 cites·16 claims
- 0697US11872203B1Methods of administering solriamfetol to lactating womenAXSOME MALTA LTD·Filed 2023·Granted Jan 16, 2024·2 cites·18 claims
- 0797US11857528B1Methods of providing solriamfetol therapy to subjects with impaired renal functionAXSOME MALTA LTD·Filed 2023·Granted Jan 2, 2024·2 cites·26 claims
- 0897US11850227B2Methods of providing solriamfetol therapy to subjects with impaired renal functionAXSOME MALTA LTD·Filed 2023·Granted Dec 26, 2023·2 cites·25 claims
- 0997US11850228B2Methods of providing solriamfetol therapy to subjects with impaired renal functionAXSOME MALTA LTD·Filed 2023·Granted Dec 26, 2023·2 cites·25 claims
- 1097US11850226B2Methods of providing solriamfetol therapy to subjects with impaired renal functionAXSOME MALTA LTD·Filed 2023·Granted Dec 26, 2023·2 cites·12 claims
- 1197US11839598B2Methods of providing solriamfetol therapy to subjects with impaired renal functionAXSOME MALTA LTD·Filed 2023·Granted Dec 12, 2023·2 cites·15 claims
- 1297US11839599B2Methods of providing solriamfetol therapy to subjects with impaired renal functionAXSOME MALTA LTD·Filed 2023·Granted Dec 12, 2023·2 cites·26 claims
- 1397US11779554B1Methods of administering solriamfetol to lactating womenAXSOME MALTA LTD·Filed 2023·Granted Oct 10, 2023·2 cites·18 claims
- 1496US11793776B1Methods of administering solriamfetol to lactating womenAXSOME MALTA LTD·Filed 2023·Granted Oct 24, 2023·2 cites·24 claims
- 1596US11648232B2Methods and compositions for treating excessive sleepinessAXSOME MALTA LTD·Filed 2021·Granted May 16, 2023·14 cites·16 claims
- 1693US12064411B1Methods of administering solriamfetol to lactating womenAXSOME MALTA LTD·Filed 2023·Granted Aug 20, 2024·1 cites·18 claims
- 1793US11497725B2Treatment for obesityAXSOME MALTA LTD·Filed 2020·Granted Nov 15, 2022·2 cites·14 claims
- 1893US11439597B2Formulations of (R)-2-amino-3-phenylpropyl carbamateAXSOME MALTA LTD·Filed 2021·Granted Sep 13, 2022·2 cites·18 claims
- 1991US2025108030A1Methods of providing solriamfetol therapy to subjects with impaired renal functionAXSOME MALTA LTD·Filed 2024·Application pending·0 cites
- 2090US2025059135A1Treatment of cataplexyAXSOME MALTA LTD·Filed 2024·Application pending·0 cites
- 2189US12390419B2Formulations of (R)-2-amino-3-phenylpropyl carbamateAXSOME MALTA LTD·Filed 2024·Granted Aug 19, 2025·0 cites·15 claims
- 2289US12194016B2Methods of providing solriamfetol therapy to subjects with impaired renal functionAXSOME MALTA LTD·Filed 2024·Granted Jan 14, 2025·0 cites·11 claims
- 2389US11986454B1Methods of providing solriamfetol therapy to subjects with impaired renal functionAXSOME MALTA LTD·Filed 2023·Granted May 21, 2024·0 cites·23 claims
- 2489US2025059136A1Carbamoyl phenylalaninol compounds and uses thereofAXSOME MALTA LTD·Filed 2024·Application pending·0 cites
- 2588US12263145B2Methods of administering solriamfetol to lactating womenAXSOME MALTA LTD·Filed 2024·Granted Apr 1, 2025·0 cites·26 claims
- 2688US2025352476A1Formulations of (r)-2-amino-3-phenylpropyl carbamateAXSOME MALTA LTD·Filed 2025·Application pending·0 cites
- 2788US2025114322A1Methods and compositions for treating excessive sleepinessAXSOME MALTA LTD·Filed 2024·Application pending·0 cites
- 2887US12162821B2Treatment of cataplexyAXSOME MALTA LTD·Filed 2023·Granted Dec 10, 2024·0 cites·20 claims
- 2986US11865098B1Methods and compositions for treating excessive sleepinessAXSOME MALTA LTD·Filed 2023·Granted Jan 9, 2024·0 cites·28 claims
- 3086US2024018098A1Carbamoyl Phenylalaninol Compounds and Uses ThereofAXSOME MALTA LTD·Filed 2023·Application pending·0 cites
- 3186US2024189270A1Methods and compositions for treating excessive sleepinessAXSOME MALTA LTD·Filed 2024·Application pending·0 cites
- 3286US2024180866A1Methods and compositions for treating excessive sleepinessAXSOME MALTA LTD·Filed 2023·Application pending·0 cites
- 3385US12201601B2Treatment for obesityAXSOME MALTA LTD·Filed 2022·Granted Jan 21, 2025·0 cites·24 claims
- 3485US12102609B2Methods of administering solriamfetol to lactating womenAXSOME MALTA LTD·Filed 2023·Granted Oct 1, 2024·0 cites·26 claims
- 3585US2025340509A1Compositions comprising (r)-2-amino-3-phenylpropyl carbamate and uses thereofAXSOME MALTA LTD·Filed 2025·Application pending·0 cites
- 3684US2025017890A1Carbamoyl phenylalaninol analogs and uses thereofAXSOME MALTA LTD·Filed 2024·Application pending·0 cites
- 3783US11998639B2Formulations of (R)-2-amino-3-phenylpropyl carbamateAXSOME MALTA LTD·Filed 2022·Granted Jun 4, 2024·0 cites·19 claims
- 3882US2025000825A1Methods of administering solriamfetol to lactating womenAXSOME MALTA LTD·Filed 2024·Application pending·0 cites
- 3979US12318362B2Methods of providing solriamfetol therapy to subjects with impaired renal functionAXSOME MALTA LTD·Filed 2021·Granted Jun 3, 2025·0 cites·11 claims
- 4079US11713292B2Treatment of cataplexyAXSOME MALTA LTD·Filed 2021·Granted Aug 1, 2023·0 cites·18 claims
- 4178US12384743B2Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereofAXSOME MALTA LTD·Filed 2022·Granted Aug 12, 2025·0 cites·7 claims
- 4278US11780805B2Carbamoyl phenylalaninol compounds and uses thereofAXSOME MALTA LTD·Filed 2021·Granted Oct 10, 2023·0 cites·18 claims
- 4376US2022401401A1Carbamoyl phenylalaninol analogs and uses thereofAXSOME MALTA LTD·Filed 2022·Application pending·0 cites
- 4475US2024041817A1Methods of providing solriamfetol therapy to subjects with impaired renal functionAXSOME MALTA LTD·Filed 2023·Application pending·0 cites
- 4570US12005036B1Methods of administering solriamfetol to lactating womenAXSOME MALTA LTD·Filed 2023·Granted Jun 11, 2024·0 cites·30 claims
- 4670US11560354B2Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereofAXSOME MALTA LTD·Filed 2020·Granted Jan 24, 2023·0 cites·8 claims
- 4769US12036194B1Methods of administering solriamfetol to lactating womenAXSOME MALTA LTD·Filed 2023·Granted Jul 16, 2024·0 cites·28 claims
- 4868US12090126B2Methods of administering solriamfetol to lactating womenAXSOME MALTA LTD·Filed 2023·Granted Sep 17, 2024·0 cites·15 claims
- 4966US2024350435A1Methods of administering solriamfetol to lactating womenAXSOME MALTA LTD·Filed 2024·Application pending·0 cites
- 5064US2025032442A1Methods and compositions for treating cognitive impairmentAXSOME MALTA LTD·Filed 2022·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →